Myocarditis
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Rhythm PharmaceuticalsBOSTON, MA
1 programMyocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC RegistryN/A1 trial
Active Trials
Clinical Trials (1)
Total enrollment: 100 patients across 1 trials
NCT05158751Rhythm PharmaceuticalsMyocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
Start: Jan 2026Est. completion: May 2026100 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space